Clinical features of asymptomatic or subclinical COVID-19 in children
LIU You-Jing, CHEN Peng, LIU Zhi-Sheng, LI Ying, DU Hui, XU Jia-Li
Department of Respiratory Medicine, Wuhan Children's Hospital/Wuhan Maternal and Child Healthcare Hospital, Tongji Medical College, Huazhong University of Science&Technology, Wuhan 430016, China
Abstract Objective To study the clinical features of asymptomatic or subclinical coronavirus disease 2019 (COVID-19) in children. Methods A retrospective analysis was performed for the clinical data of 53 children who were confirmed with asymptomatic or subclinical COVID-19, including epidemiological history, clinical typing, co-infection, time to clearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid in nasopharyngeal swabs, laboratory examination results, length of hospital stay, and treatment outcome. Results The children with asymptomatic or subclinical COVID-19 accounted for 30.5% (53/174) in children with COVID-19 hospitalized in the COVID-19 ward of Wuhan Children's Hospital. All cases occurred with familial aggregation. Among the 53 children, 35 (66%) had asymptomatic infection and 18 (34%) had subclinical infection. Mycoplasma infection was found in 17 children (32%). For the 53 children, the mean time to clearance of SARS-CoV-2 nucleic acid in nasopharyngeal swabs was 9±4 days. Most laboratory markers were maintained within the normal range. The mean hospital stay was 11±4 days. Lung CT of 18 children with subclinical COVID-19 showed ground-glass opacities, linear opacities, and patchy opacities, with relatively limited lesions. Conclusions There is a high proportion of children with asymptomatic or subclinical COVID-19 among the children with COVID-19 hospitalized in the COVID-19 ward. The transmission risk of asymptomatic or subclinical COVID-19 should be taken seriously.
World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020[EB/OL]. (2020-02-11)[2020-04-11]. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020?fbclid=IwAR3zwwW-_arNeH2eifarZKvOIxw2LH9Dc7KXdwFI_Fx4qpDKKE_u9qXpSHo.
[2]
World Health Organization. Coronavirus disease 2019(COVID-19):situation report-107[EB/OL]. (2020-05-06)[2020-05-07]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200506covid-19-sitrep-107.pdf?sfvrsn=159c3dc_2.
Wang S, Guo L, Chen L, et al. A case report of neonatal 2019 coronavirus disease in China[J]. Clin Infect Dis, 2020. DOI:10.1093/cid/ciaa225. Epub ahead of print.
Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children[J]. N Engl J Med, 2020, 382(17):1663-1665.
[11]
Chen Y, Liu Q, Guo D. Emerging coronaviruses:genome structure, replication, and pathogenesis[J]. J Med Virol, 2020, 92(4):418-423.
[12]
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women:a retrospective review of medical records[J]. Lancet, 2020, 395(10226):809-815.
Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China[J]. Sci China Life Sci, 2020, 63(5):706-711.
